Grant opportunity preview
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
Offered by National Institutes of Health
HealthcareNationalNovember 10, 2026
Opportunity summary
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Foo…
Sign in to review full eligibility requirements, application details, matching insights, and verified source links.